Finance

Lists
CONCORDBIO:NSE
Concord Biotech Ltd
₹ 1,354.80
-1.98%
(-27.30) 1D
10-р сарын 15, 15:30:00 (GMT+5:30)  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CONCORDBIO...
Open
₹ 1,390.80
High
₹ 1,394.90
Low
₹ 1,350.00
Mkt. cap
141.73Т
Avg. vol.
139.50 мян
Volume
35.98 мян
Dividend
0.56%
Quarterly dividend
₹ 1.89
Ex-dividend date
2026 оны 7-р сарын 24
P/E ratio
51.50
52-wk high
₹ 1,615.00
52-wk low
₹ 987.00
EPS
₹ 26.31
No. of employees
2 мян
Open
₹ 1,390.80
High
₹ 1,394.90
Low
₹ 1,350.00
Mkt. cap
141.73Т
Avg. vol.
139.50 мян
Volume
35.98 мян
Dividend
0.56%
Quarterly dividend
₹ 1.89
Ex-dividend date
2026 оны 7-р сарын 24
P/E ratio
51.50
52-wk high
₹ 1,615.00
52-wk low
₹ 987.00
EPS
₹ 26.31
No. of employees
2 мян
News stories
From web sources and news partners
Profile
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide. It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
About Concord Biotech Ltd
CEO-
Employees1.62 мян
Founded2000
Headquarters-
SectorPharmaceutical industry
Last report
2026 оны 8-р сарын 3
Fiscal period
Q1 2027
₹ 5.52 / ₹ 5.60
-1.43%miss
Revenue / Est. (INR)
2.57 тэрбум / 2.45 тэрбум
+5.05%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
2.47 тэрбум
2.78 тэрбум
3.26 тэрбум
2.57 тэрбум
Cost of goods sold
775.44 сая
941.71 сая
1.32 тэрбум
890.11 сая
Cost of revenue
775.44 сая
941.71 сая
1.32 тэрбум
890.11 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
444.56 сая
467.81 сая
477.71 сая
436.38 сая
Operating expense
994.14 сая
1.03 тэрбум
837.11 сая
1.04 тэрбум
Total operating expenses
1.77 тэрбум
1.98 тэрбум
2.16 тэрбум
1.93 тэрбум
Operating income
701.00 сая
802.34 сая
1.10 тэрбум
642.76 сая
Other non operating income
133.52 сая
99.76 сая
-356.29 сая
128.26 сая
EBT including unusual items
856.84 сая
861.56 сая
1.14 тэрбум
783.43 сая
EBT excluding unusual items
856.84 сая
894.31 сая
929.35 сая
783.43 сая
Income tax expense
226.21 сая
225.14 сая
256.08 сая
206.46 сая
Effective tax rate
26.40%
26.13%
22.45%
26.35%
Other operating expenses
365.67 сая
378.34 сая
163.96 сая
424.64 сая
Net income
635.81 сая
644.77 сая
887.90 сая
585.26 сая
Net profit margin
25.74%
23.21%
27.23%
22.73%
Earnings per share
6.03
6.31
8.46
5.52
Interest and investment income
-
-
24.63 сая
-
Interest expense
-591.00 мян
-815.00 мян
-840.00 мян
-364.00 мян
Net interest expenses
-591.00 мян
-815.00 мян
23.79 сая
-364.00 мян
Depreciation and amortization charges
183.92 сая
187.47 сая
195.44 сая
181.00 сая
EBITDA
881.84 сая
933.85 сая
1.28 тэрбум
824.23 сая
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс